noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

Capital One Financial Corporation

Capital One and NALCAB Further Strategic CDFI Partnership
Louisiana State University

LSU Awarded $20 Million NSF Mid-scale Grant to Build LaNeXT, a[...]
City of Fort Worth, TX

Yard, bulk waste pickup routes suspended Sept. 24

Education

Long Island University

09/23/2026 | News release | Distributed by Public on 09/24/2026 07:11

World Renowned Cancer Expert Leads International Research Platform

Dr. Nabil Hajji, a research scientist at the Dassault Systèmes Center of Excellence at LIU, is directing directing the Translational Systems Medicine Platform for Brain Tumors, a multidisciplinary initiative to develop new biomarkers, therapies, and personalized medicine for patients with brain tumors. Hajji is a world-renowned expert in the field of oncology, recognized for establishing the mechanism underlying the resistance of classical antitumor treatments in several types of cancer.

Long Island University published this content on September 23, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on September 24, 2026 at 13:11 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]

Back

View original format